Principal Healthcare Innovators ETF (NASDAQ: BTEC)

Latest News for Principal Healthcare Innovators ETF (NASDAQ:BTEC)

Principal Healthcare Innovators ETF

Sector ETFs

Short Ideas

Downgrades

Health Care

Analyst Ratings

Trading Ideas

ETFs

General

BTEC

MRNA

PowerShares ETF Trust Dynamic Biotech & Genome Port

PowerShares Dynamic Healthcare Sector Portfolio

After setting scintillating paces earlier this thanks to the race to develop a coronavirus vaccine, some health care exchange-traded funds are languishing.

3 Health Care ETFs Where Components Are Enduring Downgrades

Biotech

Long Ideas

News

GILD

IBBJ

IMMU

Biotechnology mergers and acquisitions appear to be back in a big way with news that Gilead Sciences (NASDAQ: GILD) is acquiring  Immunom

3 ETFs To Play Gilead&#39;s $21B Immunomedics Takeover

CNCR

IDNA

Shares of biotechnology company Moderna Inc (NASDAQ: MRNA) jumped 20% Monday on news that its mRNA-1273 coronavirus vaccine candidate is making positive progress.

3 ETFs For More Moderna Bets

WIIM

DMRC

Digimarc shares are trading higher after the company reported better-than-expected Q1 2024 adjusted EPS and sales.

Regency Centers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REG#NASDAQ">REG</a>) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $1.03 by 0.97 percent. The company reported quarterly sales of $363.852 million which beat the analyst consensus estimate of $358.526 million by 1.49 percent. This is a 14.43 percent increase over sales of $317.977 million the same period last year.

Earnings

Earnings Beats

Regency Centers Q1 2024 FFO $1.04 Beats $1.03 Estimate, Sales $363.852M Beat $358.526M Estimate

BOOM

DMC Global shares are trading lower after the company reported better-than-expected Q1 2024 adjusted EPS but missed sales estimates.

Second Quarter 2024 Financial Outlook
<ul>
<li>2Q24 revenue guidance of $1.4 billion to $1.5 billion</li>
<li>2Q24 Contribution Profit1 guidance of $75 million to $85 million
<ul>
<li>2Q24 Adjusted EBITDA1 guidance of $(35) million to $(25) million</li>
</ul>
</li>
</ul>

Guidance

OPEN

Opendoor Technologies Sees Q2 Revenue $1.4B-$1.5B Vs $1.48B Est.

CRDF

Cardiff Oncology shares are trading lower. The company reported Q1 financial results.

Outlook
The Company's second quarter and full-year 2024 Outlook assumes no further currency movements, acquisitions, or divestitures.
For the second quarter of 2024, RE/MAX Holdings expects:
<ul>
<li>Agent count to change negative 1.5% to 0.0% over second quarter 2023;</li>
<li>Revenue in a range of $75.0 million to $80.0 million (including revenue from the Marketing Funds in a range of $19.0 million to $21.0 million); and</li>
<li>Adjusted EBITDA in a range of $24.0 million to $27.0 million.</li>
</ul>
For the full year 2024, the Company expects:
<ul>
<li>Agent count to change negative 0.5% to positive 1.5% over full year 2023;</li>
<li>Revenue in a range of $300.0 million to $320.0 million (including revenue from the Marketing Funds in a range of $78.0 million to $82.0 million); and</li>
<li>Adjusted EBITDA in a range of $90.0 million to $100.0 million.</li>
</ul>

RMAX

RE/MAX Holdings Sees Q2 Revenue $75M-$80M Vs $78.76M Est.; FY24 Revenue $300M-$320M Vs $310.41M Est.

WillScot Mobile Mini shares are trading higher following a Q1 revenue beat.

ALHC

Alignment Healthcare shares are trading higher after the company reported better-than-expected Q1 revenue results and issued Q2 revenue guidance above estimates. Also, the company raised its FY24 revenue guidance above estimates.

Select Medical Holdings shares are trading higher after the company reported better-than-expected Q1 adjusted earnings and sales.

2024 Outlook
Our guidance for Viad consolidated, Pursuit, and GES is as follows:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">(in millions)</td>
<td colspan="1" rowspan="1">Second Quarter</td>
<td colspan="1" rowspan="1">Full Year</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Viad Consolidated</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenue</td>
<td colspan="1" rowspan="1">$352 to $377</td>
<td colspan="1" rowspan="1">Up high-single to low-double digits</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">$51 to $59</td>
<td colspan="1" rowspan="1">$171 to $191</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cash flow from Operations</td>
<td colspan="1" rowspan="1">$35 to $45</td>
<td colspan="1" rowspan="1">$120 to $140</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Capital Expenditures</td>
<td colspan="1" rowspan="1">
$20 to $25
(including growth capex of ~$5)
</td>
<td colspan="1" rowspan="1">
$65 to $70
(including growth capex of ~$20)
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Pursuit</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenue</td>
<td colspan="1" rowspan="1">$92 to $97</td>
<td colspan="1" rowspan="1">Up mid-single digits</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">$20 to $24</td>
<td colspan="1" rowspan="1">$105 to $115</td>
</tr>
<tr>
<td colspan="1" rowspan="1">GES</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenue</td>
<td colspan="1" rowspan="1">$260 to $280</td>
<td colspan="1" rowspan="1">Up low-double digits</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">$34.5 to $38.5</td>
<td colspan="1" rowspan="1">$80 to $90</td>
</tr>
</tbody>
</table>
</figure>

Viad Sees Q2 Revenue $352M-$377M Vs $328.97M Est.; FY24 Revenue Up High-Single To Low-Double Digits

TRUP

Trupanion shares are trading lower. The company reported Q1 financial results.

Orion S.A. Reiterates 2024 Adj. EBITDA Guidance Range $340M-$360M, Adj. EPS Range $2.05-$2.20 vs $2.16 Est.

SIMO

Silicon Motion shares are trading higher following strong Q2 guidance.

TXRH

Texas Roadhouse shares are trading higher after the company reported better-than-expected Q1 GAAP EPS results.

OLED

Universal Display shares are trading higher after the company reported better-than-expected Q1 2024 GAAP EPS and sales.

Business Outlook
"Our new programs with our flash maker customers are expected to continue to scale throughout this year as the move to increase outsourcing continues to build the foundation for long-term growth of our business," said Wallace Kou, President and CEO of Silicon Motion. "Our highly differentiated controller solutions enable PC and smartphone OEMs to utilize high performance, higher density and lower cost solid state storage to enable cutting edge applications such as AI-at-the-edge. Based on our strong start to the year and our increasing backlog, we are increasing our full-year outlook. We expect our business will continue to improve steadily throughout 2024 as we continue to scale new SSD and eMMC+UFS controller programs that will also improve our ASPs and profitability steadily throughout this year."
For the second quarter of 2024, management expects:
<figure class="table"> 
<table>
<tbody>
<tr>
<td>GAAP</td>
<td>Non-GAAP Adjustment</td>
<td>Non-GAAP</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Revenue</td>
<td>$199m to $208m +5% to 10% Q/Q +42% to 48% Y/Y</td>
<td>--</td>
<td>$199m to $208m +5% to 10% Q/Q +42% to 48% Y/Y</td>
</tr>
<tr>
<td>Gross margin</td>
<td>45.0% to 46.0%</td>
<td>Approximately $0.1m&#x2A;</td>
<td>45.0% to 46.0%</td>
</tr>
<tr>
<td>Operating margin</td>
<td>15.0% to 16.3%</td>
<td>Approximately $2.5m to $3.0m&#x2A;&#x2A;</td>
<td>16.5% to 17.5%</td>
</tr>
</tbody>
</table>
</figure>
&#x2A; Projected gross margin (non-GAAP) excludes $0.1 million of stock-based compensation. &#x2A;&#x2A; Projected operating margin (non-GAAP) excludes $2.5 million to $3.0 million of stock-based compensation and dispute related expenses. &nbsp;
For the full year 2024, management expects:
<figure class="table"> 
<table>
<tbody>
<tr>
<td>GAAP</td>
<td>Non-GAAP Adjustment</td>
<td>Non-GAAP</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Revenue</td>
<td>$800m to $830m +25% to 30% Y/Y</td>
<td>--</td>
<td>$800m to $830m +25% to 30% Y/Y</td>
</tr>
<tr>
<td>Gross margin</td>
<td>44.9% to 46.9%</td>
<td>Approximately $0.5m&#x2A;</td>
<td>45.0% to 47.0%</td>
</tr>
<tr>
<td>Operating margin</td>
<td>10.7 % to 13.1%</td>
<td>Approximately $30.0m to $32.0m&#x2A;&#x2A;</td>
<td>14.7% to 16.7%</td>
</tr>
</tbody>
</table>
</figure>
&#x2A; Projected gross margin (non-GAAP) excludes $0.5 million of stock-based compensation. &#x2A;&#x2A; Projected operating margin (non-GAAP) excludes $30.0 million to $32.0 million of stock-based compensation and dispute related expenses.

Silicon Motion Technology Sees Q2 Revenue $199M-$208M Vs $187.06M Est.; FY24 Revenue $800M-$830M Vs $793.25M Est.

MRDB

MariaDB shares are trading lower after Progress Software said it has no intention to make an offer for the company.

Silicon Motion Technology shares are trading higher after the company reported better-than-expected Q1 2024 adjusted EPS and sales.

Orion Engineered Carbons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OEC#NYSE">OEC</a>) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.48 by 8.33 percent. This is a 29.73 percent decrease over earnings of $0.74 per share from the same period last year. The company reported quarterly sales of $502.900 million which missed the analyst consensus estimate of $506.426 million by 0.70 percent. This is a 0.44 percent increase over sales of $500.700 million the same period last year.

Earnings Misses

Orion Engineered Carbons Q1 2024 Adj EPS $0.52 Beats $0.48 Estimate, Sales $502.900M Miss $506.426M Estimate

Nexa Res (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEXA#NYSE">NEXA</a>) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.03) by 400 percent. This is a 1400 percent decrease over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $580.000 million which beat the analyst consensus estimate of $569.990 million by 1.76 percent. This is a 13.08 percent decrease over sales of $667.318 million the same period last year.

NEXA

Nexa Res Q1 2024 Adj EPS $(0.15) Misses $(0.03) Estimate, Sales $580.000M Beat $569.990M Estimate

Investing Themes For 2024

Sectors To Watch With Potential Rate Cuts On The Horizon

Barbell Equity Exposure In '24

Dealmaking Outlook: Unsettled, With Bright Spots

Exchange-traded funds (ETFs) offer a cost-effective solution for portfolio diversification, thanks to their low expense ratios compared to individu...

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Principal Healthcare Innovators ETF (NASDAQ:BTEC)

Friday, September 25, 2020

Monday, September 14, 2020

Tuesday, May 19, 2020

Thursday, May 07, 2020